Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03429907 · ClinicalTrials.gov registry record · NA
An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast Cancer
A NA study of Malignant Neoplasm of Breast, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 62
- Enrollment target
- 1
- Study location
NCT03429907: Active NA study of Malignant Neoplasm of Breast, sponsored by M.D. Anderson Cancer Center.
NCT03429907 is a NA study of Malignant Neoplasm of Breast that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 62 participants, above the 55-participant average among 10 other Malignant Neoplasm of Breast trials with a reported enrollment target (13% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03429907, a NA study of Malignant Neoplasm of Breast, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research study is to learn if starting a stress-reduction program before treatment can affect your stress, mood, and physical symptoms during and after treatment for cancer. This is an investigational study. Up to 140 participants will be enrolled in this study. All participants will be recruited at MD Anderson.
Primary Outcome
For the primary objective, changes from T0 to T2 and T3 in neurotoxic somatic symptoms analyzed with multilevel models, in which changes over time are estimated simultaneously across groups.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
- BEHAVIORAL Mind-Body Exercises
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2017-12-05 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What the registry record for NCT03429907 still lists
NCT03429907 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, above the 55-participant average among 10 other Malignant Neoplasm of Breast trials with a reported enrollment target (13% higher).
The record links to 1 condition, with Malignant Neoplasm of Breast appearing as the primary indexed condition, and to 2 interventions - of which Questionnaires is the first listed.
NCT03429907 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03429907 about?
NCT03429907 is a clinical study titled "An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast Cancer". The goal of this research study is to learn if starting a stress-reduction program before treatment can affect your stress, mood, and physical symptoms during and after treatment for cancer. This is an investigational study. Up to 140 participants will be enrolled in this study. All participants w...
What is the current status of trial NCT03429907?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 62 participants. The study started on 2017-12-05. Estimated completion is 2026-04-30.
What conditions does trial NCT03429907 study?
This clinical trial studies the following conditions: Malignant Neoplasm of Breast.
What interventions are being tested in trial NCT03429907?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Mind-Body Exercises (BEHAVIORAL).
Who is sponsoring clinical trial NCT03429907?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03429907 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Neoplasm of Breast
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03429907's enrollment target sits among peer trials
62 4th of 10 higher than 7 of 10 other Malignant Neoplasm of Breast trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Malignant Neoplasm of Breast trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
RECRUITING · NA
-
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
RECRUITING · NA
-
Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment
COMPLETED · NA
-
A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer
RECRUITING · Phase 1
-
Selumetinib and Olaparib in Solid Tumors
ACTIVE NOT RECRUITING · Phase 1
-
Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI